In 2020, the outbreak of the pandemic stimulated consumer demand for naturally sourced plant extracts, however, China’s export value of plant extracts in the first half of 2020 reached USD1.265 billion, up only 1.08% year on year, due to export price dropping and export restrictions, while the export price dropped 6.93% year on year.
Overall export data of plant extracts in 2020
According to the data of the past decade, China’s plant extract export was in a period of high growth from 2010-2015 while it experienced a large decline in 2016-2017, and it regained growth until 2018 to achieve a record high. However, China’s export to the U.S. was temporarily impeded by the trade friction between China and the U.S. in 2019. In this year, China’s export value of plant extracts was USD2.372 billion, up 0.19% year on year; China’s export volume thereof was 86,900 tons, up 5.68% year on year; China’s export price thereof was USD27.3/kg, down 5.19% year on year. China’s export value of plant extracts was USD1.265 billion in the first half of 2020, up only 1.08% year on year, while China’s export price thereof dropped 6.93% year on year mainly due to the continued U.S. dollar devaluation, which in turn affected the total export.
In terms of export markets, the U.S., Japan, India, Spain, Mexico, Germany, South Korea, Malaysia, France and Indonesia were the top ten markets for China’s plant extract export. Among them, the U.S. was still the largest market for China’s plant extract export, with the export to the U.S. rebounding strongly in the first half of 2020 to reach USD304 million, up 27.97% year on year; the main export products included stevia extract, licorice extract, and ginkgo biloba extract. This reflects that the U.S. has large market demand for plant extracts and will continue to be the number one market for China’s plant extract export. If you are looking for plant extracts manufacturers and suppliers, then Pharmasources would be your best choice.









(All Rights Reserved)